Haemonetics Corporation (HAE)

Current ratio

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Total current assets	US$ in thousands	768,903	764,982	865,744	801,607	769,722	706,309	715,789	687,783	756,031	729,455	699,246	684,368	693,546	668,348	760,279	759,410	603,639	582,575	567,789	615,278
Total current liabilities	US$ in thousands	300,383	261,755	264,215	236,939	251,816	226,889	262,175	180,487	442,266	355,411	288,470	228,339	253,495	194,384	338,568	407,827	274,822	256,692	240,066	293,665
Current ratio		2.56	2.92	3.28	3.38	3.06	3.11	2.73	3.81	1.71	2.05	2.42	3.00	2.74	3.44	2.25	1.86	2.20	2.27	2.37	2.10

March 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $768,903K ÷ $300,383K
= 2.56

Haemonetics Corporation's current ratio has exhibited fluctuations over the past few quarters. The current ratio measures the company's ability to cover its short-term liabilities with its current assets. A higher current ratio is generally indicative of stronger liquidity and financial health.

As of March 31, 2024, the current ratio stands at 2.56, which indicates that the company has $2.56 in current assets for every $1 in current liabilities. This ratio has decreased from the previous quarter, where it was 2.92, and is lower than the company's performance in the second and third quarters of 2023.

Looking further back, Haemonetics Corporation showed a notable decline in the current ratio in the first quarter of 2022, reaching 1.71. However, the ratio improved significantly in the second quarter of 2022, peaking at 3.81, suggesting a strong liquidity position at that time.

Overall, the current ratio fluctuates, indicating varying levels of liquidity and ability to meet short-term obligations. Investors and analysts may want to examine the underlying reasons for these fluctuations to assess the company's financial stability and operational efficiency.